Integrating single-cell analysis and digital pathology for risk stratification in pancreatic cancer.
Summary
This study aimed to improve risk stratification for early liver metastasis in pancreatic ductal adenocarcinoma (PDAC) by integrating single-cell analysis and digital pathology. Researchers combined single-cell RNA sequencing (scRNA-seq) data from primary and metastatic PDAC tumors with transcriptomic, clinical, and H&E image data. They identified a four-gene signature (ARHGAP18, ASPH, EIF4EBP1, LY6D) associated with metastasis, which correlated with features extracted from pathological images. A pathology model based on these features demonstrated prognostic stratification capabilities in internal and external cohorts. This approach proposes a genotype-to-phenotype workflow linking scRNA-seq-derived metastatic features to routine histopathological images.
Analysis
The integration of single-cell analysis and digital pathology represents a significant advance for risk stratification in PDAC, a disease with often poor prognosis. By identifying a gene signature linked to metastasis and correlating it with H&E image features, this study paves the way for more accessible and less costly prognostic tools than scRNA-seq. This could enable better identification of patients at high risk of early liver metastasis, thereby facilitating more personalized therapeutic decisions and potentially the exploration of new targets to prevent tumor dissemination.